Loading...

Response to FOLFIRINOX by gender in patients with metastatic pancreatic cancer: Results from the PRODIGE 4/ ACCORD 11 randomized trial

BACKGROUND: Hohla et al. suggested that female gender could positively predict response to FOLFIRINOX in patients with advanced pancreatic cancer. In this study, we explored the response to the FOLFIRINOX regimen by gender within the trial PRODIGE4/ACCORD 11. PATIENTS AND METHODS: Data were describe...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:PLoS One
Main Authors: Lambert, Aurélien, Jarlier, Marta, Gourgou Bourgade, Sophie, Conroy, Thierry
Format: Artigo
Sprog:Inglês
Udgivet: Public Library of Science 2017
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5606928/
https://ncbi.nlm.nih.gov/pubmed/28931010
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0183288
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!